Xconomy’s Digital Events →
GNS Healthcare CEO Colin Hill (left) chats with Xconomy’s Bob Buderi about using big data analysis on a “new path to personalized medicine.”
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.